Best Financial Markets Analysis Article Regardless of whatever carrot stick the Administration or Congress dangles in front of the equity market, my work continue to warn me that since the January 6 low at 49.60 in the ProShares UltraShort Dow 30 (NYSE: DXD), the price structure has entered into a major new upleg.

As I see it, the initial upleg of the advance ended in late January at 64.26, while the digestion of the upmove ended last Friday at 57.10. The first upleg of the next advance in the DXD ended at Thursday's high of 66.26, and the decline into Friday's session was the digestion period of the upmove from 2/06 to 2/12.

As I noted to subscribers on Friday, my work suggests that somewhere between 62.50 and 60.00 the next powerful advance will begin. The DXD got down to a low of 61.86 intraday and closed at 63.92. I would only be prepared to risk 61.10 to "be there" for the next upleg.

By Mike Paulenoff

Mike Paulenoff is author of the MPTrader.com (www.mptrader.com) , a real-time diary of Mike Paulenoff's trading ideas and technical chart analysis of Exchange Traded Funds (ETFs) that track equity indices, metals, energy commodities, currencies, Treasuries, and other markets. It is for traders with a 3-30 day time horizon, who use the service for guidance on both specific trades as well as general market direction

© 2002-2009 MPTrader.com, an AdviceTrade publication. All rights reserved. Any publication, distribution, retransmission or reproduction of information or data contained on this Web site without written consent from MPTrader is prohibited. See our disclaimer.

Mike Paulenoff Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.